Results summary | View all lists in L2L MDB | View all genes in C01CA.profile.u50 |
Down-regulated at 24-48 hours following treatment of peripheral blood mononuclear cells (PBMC) with BAY 50-4798, an IL-2 receptor agonist, compared to recombinant IL-2. enrichment: 3.95-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
201631_S_AT | IER3 | G | immediate early response 3 | ||||||||||
204907_S_AT | BCL3 | G | T | D | X | P | R | S | B-cell CLL/lymphoma 3 |